NSAIDs cut cancer risk in Lynch Syndrome

Taking aspirin or ibuprofen more than halves the risk of colorectal cancer in people with Lynch Syndrome, an Australian-led study confirms.

Study participants, who had taken an NSAID for at least a month, reduced their risk of colorectal cancer by 57% with aspirin, and 65% with ibuprofen.

And the effect was greater in people who reported using the NSAIDs for more than five years, with a 75% and 74% risk